Related Experiment Video
Updated: Jul 10, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
A novel PANK2 gene mutation: clinical and molecular characteristics of patients short communication
Beata Kazek1, Ewa Jamroz, Martin Gencik
1Department of Child Neurology, Medical University of Silesia, Katowice, Poland. beakazek@op.pl
Abstract:
Pantothenate kinase-associated neurodegeneration (PKAN) is a progressive neurodegenerative disorder with autosomal recessive inheritance. The major symptoms of PKAN include the onset before the age of 20 years, progressive pyramidal and extrapyramidal signs, retinitis pigmentosa, optic atrophy, dementia, and iron depositions in the globus pallidus. The authors present 3 patients with proven molecular diagnosis of PKAN, in whom 2 novel mutations of PANK2 gene have been identified.
